Bruker

Bruker: reflections following 2025

Light at the end of the tunnel / the evolving nature of Bruker / guidance track record

Feb 13 • Crashkolnikov

NFTBC favourites BRKR and REGN both presented at the JPM Morgan Healthcare Conference

Jan 13 • Crashkolnikov

The NFTBC Digest (11 January 2026)

News and links (BMW, BRKR, PTC, REGN, WPP)

Jan 11 • Crashkolnikov

The NFTBC Digest (14 December 2025)

News and links (BMW, BRKR, PTC, REGN)

Dec 14, 2025 • Crashkolnikov

The NFTBC Digest (7 December 2025)

News and links (BMW, BRKR, PTC, REGN)

Dec 7, 2025 • Crashkolnikov

Bruker - Refections following Q3 2025

And musings on Bruker's role in next-gen lithography

Nov 4, 2025 • Crashkolnikov

Bruker - Preferred Share Offering

Reflections on dilution and the potential playbook

Sep 4, 2025 • Crashkolnikov

Bruker - Leverage & Covenants

An Addendum to Q2

Aug 13, 2025 • Crashkolnikov

Bruker - Reflections on Q2 2025

"Too many surprises to have an expectation"

Aug 5, 2025 • Crashkolnikov

Bruker - Thoughts following Q1 2025

"Playing Defense"

May 8, 2025 • Crashkolnikov

Bruker Corporation

Apr 15, 2025 • Crashkolnikov

#nojs-banner { position: fixed; bottom: 0; left: 0; padding: 16px 16px 16px 32px; width: 100%; box-sizing: border-box; background: red; color: white; font-family: -apple-system, "Segoe UI", Roboto, Helvetica, Arial, sans-serif, "Apple Color Emoji", "Segoe UI Emoji", "Segoe UI Symbol"; font-size: 13px; line-height: 13px; } #nojs-banner a { color: inherit; text-decoration: underline; } This site requires JavaScript to run correctly. Please turn on JavaScript or unblock scripts